COVID-19 - Strategic Insights Report (Page 96)

COVID-19

COVID-19 Vaccine Efficacy in Rheumatoid Arthritis Patients Affected by Time Interval and Immunosuppressive Treatment

Rheumatoid arthritis patients who have undergone COVID-19 vaccination experience a decrease in antibody production over time, with immunosuppressive treatments having a negligible effect on vaccine efficacy. This study investigated the durability of humoral immune response in rheumatoid arthritis patients following COVID-19 vaccination, comparing them to healthy controls. The researchers found

COVID-19

Suboptimal Antibody Response to COVID-19 Vaccines in Solid Organ Transplant Recipients

Adult solid organ transplant recipients who received SARS-CoV-2 vaccinations displayed suboptimal antibody responses, favoring breakthrough infections. The study, conducted by researchers at the University of Bologna, found that cell-mediated immunity (CMI) was not a strong predictor of breakthrough infections in this population. The researchers investigated the relationship between CMI and

COVID-19

COVID-19 Pandemic Exacerbates Measles Crisis in Zambia

The COVID-19 pandemic had a profound impact on childhood routine immunization programs in Zambia, resulting in increased measles mortalities and complications. Research published in Tropical Medicine and Health found that the likelihood of measles-related deaths and complications in children was significantly higher due to high rates of unvaccinated children, late

COVID-19

Higher Mortality Risk Associated with Pfizer's BNT162b2 COVID-19 Vaccine

Recent research based on state-level public health databases in Florida has found a significant higher risk of mortality among adults who received the Pfizer-developed BNT162b2 COVID-19 vaccine compared to those who received the Moderna mRNA-1273 vaccine. The study matched 1,470,100 noninstitutionalized adult Florida residents who received at least

COVID-19

COVID-19 Infection Linked to Parkinson's Disease, Suggests New Research

Researchers from Thomas Jefferson University have made a significant discovery linking COVID-19 infection to the development of Parkinson's disease. The study, which was funded by the National Institutes of Health, investigated the relationship between viral infection and Parkinsonian pathology in mice. The findings suggest that infection with the

COVID-19

Novel Fusion Polypeptide for SARS-CoV-2 Vaccination

Researchers at the University of Wellington have patented a novel fusion polypeptide designed to provide effective SARS-CoV-2 vaccination. The polypeptide, which consists of a fusion of the SARS-CoV-2 Spike protein receptor binding domain and the N-terminal domain, is aimed at preventing and treating SARS-CoV-2 infection. The fusion polypeptide is designed

COVID-19

Alternative Data Sources for Capturing Pregnancy Loss and Maternal Vaccination Data

Researchers from the University of Queensland have highlighted the need for alternative data sources to capture pregnancy loss and maternal vaccination data, particularly in the absence of comprehensive registries. A study published in Public Health explored the use of current data collection methods and sources to address gaps in maternal

COVID-19

Machine Learning Models Predict Kidney Disease Risks in Post-Pandemic Period

Research conducted at the Penn State College of Medicine has revealed a strong link between COVID-19 and acute kidney injury (AKI) and chronic kidney disease (CKD). The study aimed to use large electronic health records (EHR) and machine learning algorithms to predict the incidence of AKI and CKD during the

COVID-19

Pandemic Disruptions Exacerbate Healthcare Inequities: Study

The COVID-19 pandemic has disrupted healthcare utilization, particularly among non-COVID-19 patients, revealing persistent inequalities in healthcare access and utilization. A new study, published on medrxiv.org, analyzes electronic health records of millions of patients across the United States between 2019 and 2022, highlighting the impact of the pandemic on healthcare

COVID-19

Emerging Covid Variant LP.8.1: What You Need to Know

The Covid-19 pandemic continues to unfold, with a new variant, LP.8.1, rapidly spreading across the globe. This new strain, which originated from the JN.1 Omicron strain of Covid, has been detected in 23 countries, including the UK, where it now accounts for over 60% of all Covid

COVID-19

Federal Investigation Clears Battle Ground Public Schools of Misusing Federal Grant Money

A federal investigation has determined that Battle Ground Public Schools complied with federal regulations regarding the use of grant money from the Federal Communications Commission's Emergency Connectivity Fund, despite a 2023 state audit finding that the district lacked proper records for how the money was allocated. The district

COVID-19

Challenges in Managing Persistent COVID-19 in Immunocompromised Patients

A new report highlights the difficulties in treating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in patients with hematological malignancies who are immunocompromised due to their underlying disease or medical treatment. Researchers from the Department of Respirology in Japan present a case study of an 84-year-old man with stage

See all